TickerFactsScreenerDevelopers

GT Biopharma, Inc. (GTBP) — Operating Income

Annual figures by fiscal year, from SEC filings.

2010: -$2.50M2011: -$3.93M2012: -$3.51M2013: -$793.0K2014: -$2.40M2015: -$8.93M2016: -$9.37M2017: -$135.57M2018: -$250.07M2019: $16.06M2020: -$6.76M2021: -$57.52M2022: -$21.26M2023: -$13.58M2024: -$14.36M2025: -$12.42M-$12.42M
2010Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$12.42M+13.5%
2024-$14.36M-5.8%
2023-$13.58M+36.1%
2022-$21.26M+63.0%
2021-$57.52M-750.3%
2020-$6.76M-142.1%
2019$16.06M+106.4%
2018-$250.07M-84.5%
2017-$135.57M-1346.2%
2016-$9.37M-5.0%
2015-$8.93M-272.6%
2014-$2.40M-202.1%
2013-$793.0K+77.4%
2012-$3.51M+10.5%
2011-$3.93M-57.3%
2010-$2.50M—